Frazier Lifesciences Upsizes IPO to $120M

The SPAC registered additional shares to increase its offer to $120 million from the initial $100 million registered with the SEC last month. Underwriters have an over-allotment option for an additional 300,000 shares, which if exercised would add another $3 million to the SPAC’s raise.

Frazier intends to list on the Nasdaq under FLACU. Read more.

Total
0
Shares
Related Posts